Source: European Union
Start date : 11/12/2020
End date : 11/12/2020
European Medicines Agency, Other bodies and agencies,
Consumer affairs and public health, Covid-19,
The European medicines agency (EMA) is organising this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s specific role, to all interested parties.
It will also give the opportunity to the public and stakeholder groups to speak and share their needs, expectations and any concerns, that will be considered by EMA and the European medicines regulatory network in the decision-making process.
This event will be broadcasted live.
More information on the event